TY - JOUR
AU - G. S. Winder
AU - J. P. Arab
AU - Goswami Banerjee
AU - K. Bryce
AU - D. C. Fipps
AU - F. Hussain
AU - G. Im
AU - L. Omary
AU - A. A. Patel
AU - S. Patel
AU - S. Rubman
AU - M. Serper
AU - A. Shenoy
AU - J. Suzuki
AU - P. Zimbrean
AU - K. Brown
AU - M. Abouljoud
AU - J. L. Mellinger
A1 - 
AB - Hazardous alcohol use remains a major contributor to acute and chronic liver disease, while alcohol-associated liver disease (ALD) is a leading indication for liver transplantation. In recent years, embedded, interprofessional ALD clinics have improved access to alcohol use disorder care within hepatology and liver transplantation, but more work is needed to meet this challenge. The literature is lacking regarding scaling procedures to provide services for increasingly large ill patient populations. This article begins to fill this gap by describing "expanded ALD care": broad, innovative, longitudinal, interprofessional care delivery strategies surpassing standalone clinics. Drawing from analogous patient populations served by collaborative models in primary care and comprehensive eating disorder treatment, the expanded ALD care framework proposes practical strategies toward specific innovations: equipoise between biomedical and psychosocial care elements, increased clinician number and reach, long-term patient relationships, harm reduction and palliative care, outreach to external agencies and clinicians, and enhanced support for patients and families. The article also defines attributes of innovative healthcare systems that support expanded ALD care.
AD - Department of Psychiatry and Behavioral Medicine, Henry Ford Health, Detroit, Michigan, USA.; Department of Surgery, Henry Ford Health, Detroit, Michigan, USA.; Department of Psychiatry, Michigan State University, East Lansing, Michigan, USA.; Department of Surgery, Michigan State University, East Lansing, Michigan, USA.; Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan, USA.; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Psychiatry, Stanford University, Palo Alto, California, USA.; Department of Internal Medicine, Columbia University, New York City, New York, USA.; Department of Psychiatry, Vanderbilt University, Nashville, Tennessee, USA.; Department of Internal Medicine, University of California-Los Angeles, Los Angeles, California, USA.; Department of Psychiatry, Yale University, New Haven, Connecticut, USA.; Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Psychiatry, Columbia University, New York City, New York, USA.; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Internal Medicine, Henry Ford Health, Detroit, Michigan, USA.; Department of Internal Medicine, Wayne State University, Detroit, Michigan, USA.; Department of Internal Medicine, Michigan State University, East Lansing, Michigan, USA.; Department of Surgery, Wayne State University, Detroit, Michigan, USA.
AN - 40359009
BT - Liver Transpl
C5 - Opioids & Substance Use
DA - May 13
DO - 10.1097/lvt.0000000000000638
DP - NLM
ET - 20250513
JF - Liver Transpl
LA - eng
N2 - Hazardous alcohol use remains a major contributor to acute and chronic liver disease, while alcohol-associated liver disease (ALD) is a leading indication for liver transplantation. In recent years, embedded, interprofessional ALD clinics have improved access to alcohol use disorder care within hepatology and liver transplantation, but more work is needed to meet this challenge. The literature is lacking regarding scaling procedures to provide services for increasingly large ill patient populations. This article begins to fill this gap by describing "expanded ALD care": broad, innovative, longitudinal, interprofessional care delivery strategies surpassing standalone clinics. Drawing from analogous patient populations served by collaborative models in primary care and comprehensive eating disorder treatment, the expanded ALD care framework proposes practical strategies toward specific innovations: equipoise between biomedical and psychosocial care elements, increased clinician number and reach, long-term patient relationships, harm reduction and palliative care, outreach to external agencies and clinicians, and enhanced support for patients and families. The article also defines attributes of innovative healthcare systems that support expanded ALD care.
PY - 2025
SN - 1527-6465
ST - From embedded interprofessional clinics to expanded alcohol-associated liver disease programs
T1 - From embedded interprofessional clinics to expanded alcohol-associated liver disease programs
T2 - Liver Transpl
TI - From embedded interprofessional clinics to expanded alcohol-associated liver disease programs
U1 - Opioids & Substance Use
U3 - 10.1097/lvt.0000000000000638
VO - 1527-6465
Y1 - 2025
ER -